awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28304566-D5E4AD2E-5A80-46E3-AF99-F87750030ADA
Q28304566-D5E4AD2E-5A80-46E3-AF99-F87750030ADA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28304566-D5E4AD2E-5A80-46E3-AF99-F87750030ADA
A phase I, open-label study of trebananib combined with sorafenib or sunitinib in patients with advanced renal cell carcinoma
P2860
Q28304566-D5E4AD2E-5A80-46E3-AF99-F87750030ADA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28304566-D5E4AD2E-5A80-46E3-AF99-F87750030ADA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8ea2f6cda288bc00ffd824ce9df254848a78efc9
P2860
Sunitinib: from rational design to clinical efficacy.